Intellia Therapeutics Inc (NTLA): Kapitalflussrechnung
Kennzahl in 1000 USD | TTM 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 59.506 | 67.671 | 57.877 | 36.275 | 52.121 | 33.053 | 57.994 | 43.103 | 30.434 | 26.117 | 16.479 | 6.044 |
Cashflow aus operativer Geschäftstätigkeit | -463.989 | -348.880 | -348.880 | -394.086 | -333.287 | -225.030 | -49.912 | -103.240 | -61.257 | -65.276 | 36.109 | -1.763 |
▸ Operative Cashflow Marge | -779,73% | -515,55% | -602,8% | -1.086,38% | -639,45% | -680,82% | -86,06% | -239,52% | -201,28% | -249,94% | 219,12% | -29,17% |
Investitionsausgaben (CapEx) | 2.122 | 5.778 | 5.778 | 13.985 | 58.390 | 12.756 | 3.585 | 6.794 | 6.358 | 10.091 | 6.165 | 2.554 |
Cashflow aus Investitionstätigkeit | 17.841 | 125.567 | 125.567 | -31.347 | 160.309 | -550.778 | -214.487 | 25.176 | -260.782 | -10.091 | -6.165 | -2.554 |
Cashflow aus Finanzierungstätigkeit | 380.088 | 185.747 | 185.747 | 130.323 | 582.955 | 736.688 | 371.779 | 76.434 | 40.217 | 142.981 | 167.304 | 70.288 |
Freier Cashflow | -466.111 | -354.658 | -354.658 | -408.071 | -391.677 | -237.786 | -53.497 | -110.034 | -67.615 | -75.367 | 29.944 | -4.317 |
▸ Freie Cashflow Marge | -783,3% | -524,09% | -612,78% | -1.124,94% | -751,48% | -719,41% | -92,25% | -255,28% | -222,17% | -288,57% | 181,71% | -71,43% |
Ausgeschüttete Dividenden | - | - | - | - | - | - | - | - | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | 582.955 | 1.861.018 | 371.779 | 76.434 | 40.217 | 142.981 | -100 | -2.671 |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.